Central serous chorioretinopathy: Treatment with laser

Maurizio Battaglia Parodi; Alessandro Arrigo; Pierluigi Iacono; Bruno Falcomatà; Francesco Bandello

doi:10.3390/ph13110359

Central serous chorioretinopathy: Treatment with laser

Maurizio Battaglia Parodi, Alessandro Arrigo, Pierluigi Iacono, Bruno Falcomatà, Francesco Bandello

Fondazione G.B. Bietti

Research output: Contribution to journal › Review article › peer-review

Abstract

Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points, as evidenced on fluorescein angiography, was largely used in the past, but now, it is almost completely abandoned, owing to the potential complications. Several studies confirmed the positive effects achieved by subthreshold laser treatment in CSC, even though its improper application in the PLACE trial has questioned the effectiveness.

Original language	English
Article number	359
Pages (from-to)	1-15
Number of pages	15
Journal	Pharmaceuticals
Volume	13
Issue number	11
DOIs	https://doi.org/10.3390/ph13110359
Publication status	Published - Nov 2020

Keywords

Central serous chorioretinopathy
Laser treatment
Subthreshold laser

ASJC Scopus subject areas

Molecular Medicine
Pharmaceutical Science

Access to Document

10.3390/ph13110359

Cite this

@article{385236cf206a4898a16fa86e853dba88,

title = "Central serous chorioretinopathy: Treatment with laser",

abstract = "Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points, as evidenced on fluorescein angiography, was largely used in the past, but now, it is almost completely abandoned, owing to the potential complications. Several studies confirmed the positive effects achieved by subthreshold laser treatment in CSC, even though its improper application in the PLACE trial has questioned the effectiveness.",

keywords = "Central serous chorioretinopathy, Laser treatment, Subthreshold laser",

author = "Parodi, {Maurizio Battaglia} and Alessandro Arrigo and Pierluigi Iacono and Bruno Falcomat{\`a} and Francesco Bandello",

note = "Funding Information: Acknowledgments: The research for this paper was financially supported by the Italian Ministry of Health and Fondazione Roma. Publisher Copyright: {\textcopyright} 2020 by the authors. Licensee MDPI, Basel, Switzerland. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2020",

month = nov,

doi = "10.3390/ph13110359",

language = "English",

volume = "13",

pages = "1--15",

journal = "Pharmaceuticals",

issn = "1424-8247",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "11",

}

TY - JOUR

T1 - Central serous chorioretinopathy

T2 - Treatment with laser

AU - Parodi, Maurizio Battaglia

AU - Arrigo, Alessandro

AU - Iacono, Pierluigi

AU - Falcomatà, Bruno

AU - Bandello, Francesco

N1 - Funding Information: Acknowledgments: The research for this paper was financially supported by the Italian Ministry of Health and Fondazione Roma. Publisher Copyright: © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2020/11

Y1 - 2020/11

N2 - Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points, as evidenced on fluorescein angiography, was largely used in the past, but now, it is almost completely abandoned, owing to the potential complications. Several studies confirmed the positive effects achieved by subthreshold laser treatment in CSC, even though its improper application in the PLACE trial has questioned the effectiveness.

AB - Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points, as evidenced on fluorescein angiography, was largely used in the past, but now, it is almost completely abandoned, owing to the potential complications. Several studies confirmed the positive effects achieved by subthreshold laser treatment in CSC, even though its improper application in the PLACE trial has questioned the effectiveness.

KW - Central serous chorioretinopathy

KW - Laser treatment

KW - Subthreshold laser

UR - http://www.scopus.com/inward/record.url?scp=85095790785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095790785&partnerID=8YFLogxK

U2 - 10.3390/ph13110359

DO - 10.3390/ph13110359

M3 - Review article

AN - SCOPUS:85095790785

VL - 13

SP - 1

EP - 15

JO - Pharmaceuticals

JF - Pharmaceuticals

SN - 1424-8247

IS - 11

M1 - 359

ER -

Central serous chorioretinopathy: Treatment with laser

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this